Quality of Life and Safety Outcomes after First-Line Treatment of Symptomatic AF with Cryoablation or Drug Therapy: A Meta-Analysis of Randomized Controlled Trials

Quality of Life and Safety Outcomes after First-Line Treatment of Symptomatic AF with Cryoablation or Drug Therapy: A Meta-Analysis of Randomized Controlled Trials

Background: Cryoablation has emerged as a recognized interventional strategy for the treatment of atrial fibrillation (AF). Numerous trials have investigated cryoablation as a first-line therapy for AF. This meta-analysis aimed to evaluate the impact of cryoablation on quality of life (QoL) and safe...

Full description

Bibliographic Details
Main Authors:	Qingchun Song, Haoyu Tan, Benli Yang, Hongduan Liu, Chengming Fan
Format:	Article
Language:	English
Published:	IMR Press 2024-02-01
Series:	Reviews in Cardiovascular Medicine
Subjects:	atrial fibrillation cryoablation anti-arrhythmic drug meta-analysis quality of life first-line treatment
Online Access:	https://www.imrpress.com/journal/RCM/25/2/10.31083/j.rcm2502071

Similar Items

Comparison of cryoablation success in persistent and paroxysmal atrial fibrillation: single center experience
by: Naci Babat, et al.
Published: (2020-02-01)

Determination of the effects of cryoablation for atrial fibrillation on esophageal functions
by: Muhammet Buğra Karaaslan, et al.
Published: (2020-03-01)

Cryoablation for atrial fibrillationKey Findings
by: Jason G. Andrade, MD, FHRS
Published: (2020-04-01)

Failure to reach the optimal temperature during cryoablation due to refrigerant cylinder problem
by: Narendra Kumar, et al.
Published: (2015-01-01)

Results of a 4-Year Follow Up of Patients with Paroxysmal and Persistent Atrial Fibrillation after Cryoablation
by: Greta Radauskaite, et al.
Published: (2023-11-01)

Catheter Ablation vs. Anti-Arrhythmic Drugs as First-Line Treatment in Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Andrea Saglietto, et al.
Published: (2021-05-01)

Comparison of efficacy of pharmacological cardioversion with antazoline and propafenone versus electrical cardioversion in atrial fibrillation during cryoablation
by: Konrad Klocek, et al.
Published: (2024-03-01)

Resource use and clinical outcomes in patients with atrial fibrillation with ablation versus antiarrhythmic drug treatment
by: Julian W. E. Jarman, et al.
Published: (2018-11-01)

Effectiveness and Safety of Cryoablation in Patients With Atrial Fibrillation Episodes of <24 h Duration: A Propensity-Matched Analysis
by: Chunying Jiang, et al.
Published: (2021-10-01)

Isolation of the superior vena cava by ultra‐low temperature cryoablation
by: Khalid Bin Waleed, et al.
Published: (2024-04-01)

Isolated left atrial cryoablation of atrial fibrillation in conventional mitral valve surgery
by: Giuseppe Gatti, et al.
Published: (2020-12-01)

Role of Heat Shock Proteins in Atrial Fibrillation: From Molecular Mechanisms to Diagnostic and Therapeutic Opportunities
by: Daiqi Liu, et al.
Published: (2022-12-01)

Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation
by: Hanna Lenhoff, et al.
Published: (2021-07-01)

The long-term effect of thermal-guided second-generation cryoablation in paroxysmal and persistent atrial fibrillation
by: Rajdip Dulai, et al.
Published: (2021-09-01)

Assessment of the effect of left atrial cryoablation enhanced by ganglionated plexi ablation in the treatment of atrial fibrillation in patients undergoing open heart surgery
by: Jiří Bárta, et al.
Published: (2017-08-01)

CRYOABLATION IN ATRIAL FIBRILLATION: RATIONALE OF THE NATIONAL PROSPECTIVE REGISTRY AND PRELIMINARY RESULTS
by: E. N. Mikhailov, et al.
Published: (2018-08-01)

Objective and subjective assessment of the recurrence of atrial fibrillation after cryoballoon ablation of the pulmonary veins
by: Sergey A. Vachev, et al.
Published: (2021-07-01)

Inflammatory Markers as Predictors of Atrial Fibrillation Recurrence: Exploring the C-Reactive Protein to Albumin Ratio in Cryoablation Patients
by: Eyup Ozkan, et al.
Published: (2023-09-01)

THE FIRST EXPERIENCE OF PULMONARY VEINS CRYOABLATION IN THE TREATMENT OF ATRIAL FIBRILLATION
by: F V Sklyarov, et al.
Published: (2017-03-01)

Cryoballoon catheter ablation or drug therapy to delay progression of atrial fibrillation: A single-center randomized trial
by: Jun Ding, et al.
Published: (2022-10-01)

Current practice in the management of new-onset atrial fibrillation in critically ill patients: a UK-wide survey
by: Chung Shen Chean, et al.
Published: (2017-09-01)

The Era of Rhythm Control: A Review of the Epidemiology and Clinical Impact of Anti-Arrhythmic Medications in Atrial Fibrillation
by: Cicely Anne Dye, et al.
Published: (2023-03-01)

Surgical Treatment of Chronic Atrial Fibrillation—Unipolar Radiofrequency Ablation versus Cryoablation, and Left Atrial versus Bi-atrial Maze Procedures
by: Masaharu Yoshikawa, MD PhD, et al.
Published: (2006-01-01)

Pressure-Guided cryoablation of pulmonary veins in atrial fibrillation: A fast and effective strategy
by: Amol Raizada, MD, et al.
Published: (2017-03-01)

Pulmonary vein parameters are similar or better predictors than left atrial diameter for paroxysmal atrial fibrillation after cryoablation
by: Bolin Li, et al.

Solving difficulties in transseptal sheath crossing: The shoehorn technique
by: Juan Benezet‐Mazuecos, et al.
Published: (2023-12-01)

Esophageal ulcers secondary to cryoenergy after pulmonary vein ablation using the second-generation balloon
by: Luis Álvarez- Acosta, et al.
Published: (2018-04-01)

Evaluation of Early and Intermediate Outcomes of Cryo-Maze Procedure for Atrial Fibrillation
by: Alireza Yaghoubi, et al.
Published: (2013-07-01)

Parahisian Atrial Tachycardia: Cryoablation from the Aortic Cusp
by: Dursun Aras, MD, et al.
Published: (2014-01-01)

Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option
by: Manuel Kraft, et al.
Published: (2021-03-01)

A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting
by: Xin Du, et al.
Published: (2017-07-01)

Subclinical Dysfunction of Left Atrial Compliance after Cryoballoon versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation
by: Ewa Pilichowska-Paszkiet, et al.
Published: (2023-07-01)

Comparison of the acute outcome of two cryoballoon technologies for pulmonary vein isolation: An updated systematic review and meta-analysis
by: Amira Assaf, et al.
Published: (2022-10-01)

Meta-analysis of cryoablation versus radiofrequency ablation in the treatment of malignant liver tumors
by: Xiangzhong Huang, et al.
Published: (2024-12-01)

Comparison of landiolol and amiodarone for the treatment of new-onset atrial fibrillation after cardiac surgery (FAAC) trial: study protocol for a randomized controlled trial
by: Edouard Caspersen, et al.
Published: (2023-05-01)

Pulmonary Veins Morphometric Characteristics and Spatial Orientation Influence on Its Cryoballoon Isolation Results
by: Sergey Mamchur, et al.
Published: (2022-05-01)

Procedural performance between two cryoballoon systems for ablation of atrial fibrillation depends on pulmonary vein anatomy
by: Vincent Menger, et al.
Published: (2023-06-01)

Comparison of Radiofrequency Ablation and Cryoablation for the Recovery of Atrial Contractility and Survival
by: Kang Min Kim, et al.
Published: (2018-08-01)

Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man
by: Bo Hjorth Bentzen, et al.
Published: (2020-05-01)

Ablation versus medication as initial therapy for paroxysmal atrial fibrillation: An updated meta‐analysis of randomized controlled trials
by: Jakrin Kewcharoen, et al.
Published: (2021-12-01)